Updates

The COVID-19 Updates and Situation Report brings together news about the Global Fund partnership’s response to the pandemic. We publish a new issue when there are developments. The situation reports and news are brought together here.

  • 20 July 2022
    Urgent C19RM Reinvestments
    Due to the changing nature of the COVID-19 pandemic and contributing factors, the Global Fund will be supporting implementing countries to urgently reinvest COVID-19 Response Mechanism (C19RM) funds, where the initial intent of these investments no l...
  • 20 May 2022
    Refocusing C19RM Investments to Maximize Impact
    The COVID-19 pandemic is evolving and so should C19RM investments. The Global Fund would like to support implementing countries to rethink how these funds need to be adapted to countries’ needs in a very dynamic pandemic context.
  • 04 May 2022
    COVID-19 Clinical Therapeutics
    In this operational update, we would like to give you an update on COVID-19 testing and therapeutics that can be currently supported through the Global Fund’s COVID-19 Response Mechanism (C19RM), following WHO guidelines.
  • 21 April 2022
    Update on the C19RM Health Product Management Template (HPMT)
    The C19RM Health Products Management Template has been updated to include TB cartridges (GeneXpert and Truenat). Principal Recipients can now procure these health products to support integrated testing of tuberculosis and COVID-19 under C19RM 2021 fi...
  • 18 March 2022
    COVID-19 Self-Testing: Survey
    The Global Fund is seeking information on the readiness and use of SARS-CoV-2 antigen-detection rapid diagnostic tests for COVID-19 self-testing in countries implementing Global Fund-supported programs.
  • 04 March 2022
    Introducing Project STELLAR